SCHEMBL5174595

SCHEMBL5174595

O=C(Nc1ccccc1)Oc1ccc(OCCN2CCC(O)(c3ccc(Cl)cc3)CC2)cc1

nearest known ligand 0.64

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ KCNA5 P22460 6/20 0.60
▸ DRD2 P14416 4/20 0.56
▸ SLC6A4 P31645 2/20 0.56
▸ HRH1 P35367 2/20 0.56
▸ HTR1A P08908 1/20 0.56
▸ DRD1 P21728 1/20 0.56
▸ DRD5 P21918 1/20 0.56
▸ SLC6A2 P23975 1/20 0.56
▸ HTR2A P28223 1/20 0.56
▸ HTR7 P34969 1/20 0.56
▸ DRD3 P35462 1/20 0.56
▸ HTR2B P41595 1/20 0.56
▸ HRH3 Q9Y5N1 2/20 0.53
▸ CCR3 P51677 2/20 0.52
▸ OPRM1 P35372 4/20 0.51
▸ OPRL1 P41146 2/20 0.51
▸ MEN1 O00255 1/20 0.51
▸ ALDH1A1 P00352 1/20 0.51
▸ LMNA P02545 1/20 0.51
▸ KMT2A Q03164 1/20 0.51

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL5175324 0.93 KCNA5 (0.54) KCNA5HRH3MEN1ALDH1A1LMNA
SCHEMBL5175362 0.90 MEN1 (0.55) KCNA5HRH3MEN1ALDH1A1LMNA
SCHEMBL5174629 0.88 MEN1 (0.57) DRD2SLC6A4HRH1HTR1ADRD1
SCHEMBL5175935 0.87 ALDH1A1 (0.51) KCNA5MEN1ALDH1A1LMNAKMT2A
SCHEMBL5174590 0.85 OPRM1 (0.58) KCNA5DRD2SLC6A4HRH1HTR1A
SCHEMBL5174431 0.85 MET (0.47) KCNA5MEN1ALDH1A1LMNAKMT2A
SCHEMBL7407915 0.84 DRD2 (0.68) DRD2SLC6A4HRH1HTR1ADRD1
Hydrochloric Acid SCHEMBL7406946 0.83 DRD2 (0.67) DRD2SLC6A4HRH1HTR1ADRD1
SCHEMBL5943785 0.82 HTT (0.50) KCNA5MEN1ALDH1A1LMNAKMT2A
SCHEMBL5175575 0.81 SIGMAR1 (0.53) DRD2HTR1ACCR3OPRM1OPRL1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 6 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1868605-A2 PHENYL AND PYRIDYL LTA4H MODULATORS Janssen Pharmaceutica, N.V. (BE) 2007-12-26 — — EP claimed
WO-2006105304-A2 PHENYL AND PYRIDYL LTA4H MODULATORS JANSSEN PHARMACEUTICA N.V. (BE) 2006-10-05 — — WO claimed
US-20060223792-A1 Phenyl and pyridyl LTA4H modulators JANSSEN PHARMACEUTICA N.V. (BE) 2006-10-05 — — US claimed
EP-1868605-A2 PHENYL AND PYRIDYL LTA4H MODULATORS Janssen Pharmaceutica, N.V. (BE) 2007-12-26 — — EP disclosed
WO-2006105304-A2 PHENYL AND PYRIDYL LTA4H MODULATORS JANSSEN PHARMACEUTICA N.V. (BE) 2006-10-05 — — WO disclosed
US-20060223792-A1 Phenyl and pyridyl LTA4H modulators JANSSEN PHARMACEUTICA N.V. (BE) 2006-10-05 — — US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20060223792-A1 Phenyl and pyridyl LTA4H modulators LTA4H, LTB4R, LTC4S KCNA5 3023/4885DRD2 4672/4885SLC6A4 2062/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback